DANIEL PELTIER, M.D.
Medical Practice in Ann Arbor, MI
License number
Michigan 4301100694
Category
Medical Practice
Type
Pediatrics
Address
Address
1500 Mpb, Ann Arbor, MI 48109
Phone
(734) 763-5589
(734) 763-4208 (Fax)
(734) 763-4208 (Fax)
Personal information
See more information about DANIEL PELTIER at radaris.comName
Address
Phone
7400 Potomac, Center Line, MI 48015
43289 Carlyle Pl APT 633, Clinton Twp, MI 48038
39423 Van Dyke Ave APT 402, Sterling Heights, MI 48313
1146 Shoman St #34, Waterford, MI 48327
1146 Shoman St, Waterford, MI 48327
Professional information
Dr. Daniel C Peltier, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Pediatrics
Address:
400 E Eisenhower Pkwy SUITE B, Ann Arbor 48108
(734) 232-2600 (Phone), (734) 232-3343 (Fax)
Briarwood Center For Women Children & Young Adults
400 E Eisenhower Pkwy SUITE 2, Ann Arbor 48108
(734) 232-2600 (Phone)
HOUSE OFFICERS-PEDIATRICS
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
(734) 764-5173 (Phone), (734) 763-4208 (Fax)
(734) 232-2600 (Phone), (734) 232-3343 (Fax)
Briarwood Center For Women Children & Young Adults
400 E Eisenhower Pkwy SUITE 2, Ann Arbor 48108
(734) 232-2600 (Phone)
HOUSE OFFICERS-PEDIATRICS
1500 E Medical Center Dr SUITE 5718, Ann Arbor 48109
(734) 764-5173 (Phone), (734) 763-4208 (Fax)
Languages:
English
Education:
Medical School
University of Mi Med Sch
Graduated: 2008
University of Mi Med Sch
Graduated: 2008
Alphavirus Inhibitors And Uses Thereof
US Patent:
2010015, Jun 17, 2010
Filed:
Nov 16, 2009
Appl. No.:
12/619117
Inventors:
David J. Miller - Chelsea MI, US
Daniel C. Peltier - Ann Arbor MI, US
Weiping Peng - Ann Arbor MI, US
Daniel C. Peltier - Ann Arbor MI, US
Weiping Peng - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/496, C07D 495/04, A61K 31/454, C07D 401/14, A61P 31/12
US Classification:
51425309, 546198, 514321, 544364
Abstract:
The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of alphaviruses.